Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hayashi, Nobuhiko ^a   George, Joseph ^a   Takeuchi, Masayoshi ^a   Fukumura, Atsushi ^a   Toshikuni, Nobuyuki ^a   Arisawa, Tomiyasu ^a   Tsutsumi, Mikihiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACETALDEHYDE; ACETALDEHYDE DERIVED ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FATTY DEGENERATION; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT; STELLATE CELL;

ACETALDEHYDE; ALDEHYDES; ANIMALS; CELLS, CULTURED; ETHANOL; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATOCYTES; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; RATS; RATS, WISTAR;

EID: 84880836987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070034     Document Type: Article

References (35)

1. Beier JI, McClain CJ, (2010) Mechanisms and cell signaling in alcoholic liver disease. Biol Chem 391: 1249-1264.
2. Gao B, Bataller R, (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141: 1572-1585.
3. Setshedi M, Wands JR, Monte SM, (2010) Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 3: 178-185.
4. Yu HS, Oyama T, Isse T, Kitagawa K, Pham TT, et al. (2010) Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chem Biol Interact 188, 367-375.
5. Freeman TL, Tuma DJ, Thiele GM, Klassen LW, Worrall S, (2005) Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res 29: 1310-1316.
6. Eriksson CJ, (2001) The role of acetaldehyde in the actions of alcohol (Update 2000). Alcohol Clin Exp Res 25: 15S-32S.
7. Jeong KS, Soh Y, Jeng J, Felder MR, Hardwick JP, et al. (2000) Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver. Arch Biochem Biophys 384: 81-87.
8. Brownlee M, (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234.
9. Vlassara H, Bucala R, Striker L, (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151.
10. Singh R, Barden A, Mori T, Beilin L, (2001) Advanced glycation end-products: a review. Diabetologia 44: 129-146.
11. Vlassara H, (1997) Recent progress in advanced glycation end products and diabetic complications. Diabetes 46: S19-25.
12. Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, et al. (2007) Elevated levels of serum advanced glycation endproducts in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22: 1112-1119.
13. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, et al. (1998) Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 153: 1149-1155.
14. Kimura Y, Hyogo H, Yamagishi S, Takeuchi M, Ishitobi T, et al. (2010) Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroneterol 45: 750-757.
15. Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T, (1999) Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol Med 5: 393-405.
16. Li J, Liu D, Sun L, Lu Y, Zhang Z, (2012) Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 317: 1-5.
17. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, et al. (2000) Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 6: 114-125.
18. Takeuchi M, Yanase Y, Matsuura N, Yamagishi S, Kameda Y, et al. (2001) Immunological detection of a novel advanced glycation end-product. Mol Med 7: 783-791.
19. Takeuchi M, Makita Z, (2001) Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo. Curr Mol Med 1: 305-315.
20. Takeuchi M, Watai T, Sasaki N, Choei H, Iwaki M, et al. (2003) Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons. J Neuropathol Exp Neurol 62: 486-496.
21. Papeleu P, Vanhaecke T, Henkens T, Elaut G, Vinken M, et al. (2006) Isolation of rat hepatocytes. Methods Mol Biol 320: 229-237.
22. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
23. Schiller CD, Kainz A, Mynett K, Gescher A, (1992) Assessment of viability of hepatocytes in suspension using the MTT assay. Toxicol In Vitro 6: 575-578.
24. Lieber CS, DeCarli LM, (1970) Quantitative relationship between amount of dietary fat and severity of alcoholic fatty liver. Am J Clin Nutr 23: 474-478.
25. George J, Tsutsumi M, (2007) siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 14: 790-803.
26. Takeuchi M, Takino J, Yamagishi S, (2010) Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Targets 11: 1468-1482.
27. Popper H, Lieber CS, (1980) Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98: 695-716.
28. Watabiki T, Tokiyasu T, Yoshida M, Okii Y, Yoshimura S, et al. (1999) Intralobular distribution of class I alcohol dehydrogenase and aldehyde dehydrogenase 2 activities in the hamster liver. Alcohol Clin Exp Res 23: 52S-55S.
29. Yamauchi M, Potter J, Mezey E, (1988) Lobular distribution of alcohol dehydrogenase in the rat liver. Hepatology 8: 243-247.
30. Lieber CS, (2004) The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 36: 511-529.
31. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS, (1989) The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10: 437-446.
32. Lu Y, Cederbaum AI, (2008) CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44: 723-738.
33. Wu D, Cederbaum AI, (2009) Oxidative stress and alcoholic liver disease. Semin Liver Dis 29: 141-154.
34. Cederbaum AI, Lu Y, Wu D, (2009) Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 83: 519-548.
35. Nordmann R, (1994) Alcohol and antioxidant systems. Alcohol Alcohol 29: 513-522.